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Abstract: (1) Introduction: vitamin D may maintain the telomere length, either directly or via the
inflammation effect and/or modulating the rate of cell proliferation. Whilst results from cross-
sectional studies investigating the association between 25(OH)D concentration and telomere length
have been mixed, there is a dearth of data from prospective studies which have assessed these
associations. This study aimed to examine the association between 25(OH)D concentration in plasma
and telomere length in blood cells in very-old adults (≥85 years old) at baseline, 18 months and
36 months by controlling for related lifestyle factors. (2) Methodology: our prospective cohort
study comprised 775 participants from the Newcastle 85+ Study who had 25(OH)D measurements
at baseline. Plasma 25(OH)D was stratified as <25 nmol/L (low), 25–50 nmol/L (moderate) and
>50 nmol/L (high). Peripheral blood mononuclear cell telomere length was measured by quantita-
tive real-time polymerase chain reaction at baseline, 18 and 36 months from baseline. (3) Results:
a positive significant association was found between 25(OH)D concentration and telomere length
amongst very-old participants at baseline (95% CI = 12.0–110.3, B = 61.2 ± 5.0, p = 0.015). This
association was negative at 18 months (95% CI = −59.9–−7.5, B = −33.7 ± 13.3, p = 0.012) but was
non-significant at 36 months. (4) Conclusion: Circulating 25(OH)D concentration shows inconsistent
relationships with telomere length over time in very-old (85+ year old) adults.
Keywords: ageing; vitamin D; telomere length
1. Introduction
Telomeres, the specific deoxyribonucleic acid (DNA) protein structures, are the cap at
both ends of each chromosome. Telomeres play an essential role in protecting the genome
against nucleolytic destruction, recombination, repair, and interchromosomal fusion [1].
Each DNA replication causes telomere shortening and at the point when telomeres reach
a critical limit, the cell undergoes senescence and/or apoptosis [2]. The enzyme telom-
erase plays a key role in the maintenance of telomere length [3]. Age is a well-established
factor associated with telomere shortening [3,4]. In humans, telomere length decreases at
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a rate of 24.8–27.7 base pairs per year [2]. While telomere attrition with age is linked to
a variety of age-related diseases and their complications, telomere attrition with ageing
has been documented in multiple investigations regardless of the existence of any age-
related disorders [3]. These observations support the view that shortened telomeres may
serve as a potential candidate biomarker of ageing [3]. Telomere length is also affected by
a combination of factors, including sex, genetics and lifestyle [2]. On the other hand, it is
purported that the cellular and tissue defects associated with telomere dysfunction are
mediated in part by oxidative stress and chronic inflammation mechanisms [5]. Acceler-
ated telomere shortening is associated with mortality and many age-associated diseases,
such as cardiovascular diseases, type 2 diabetes mellitus (T2DM), Alzheimer’s disease [1],
as well as immune and infectious diseases [6] (Figure 1).
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Figure 1. Schematic overview of the role of telomeres in tissue dysfunction and chronic disease.
Evidence from animal models as well as human studies have demonstrated that
various nutrients (e.g., folate, niacin, vitamin C, magnesium, zinc and omega-3 fatty acids),
bioactives (e.g., polyphenols) and whole foods (e.g., tea) may influence telomere length and
telomere attrition through mechanisms related to cellular functions including DNA repair
and chromosome maintenance, DNA methylation, inflammation, oxidative stress and
telomerase activity I (For review see [7]). Vitamin D may influence telomere length through
its biologically active hormone 1α,25 dihydroxyvitamin D3 (calcitriol) [8]. Calcitriol is
a potent immunosuppressant and has strong anti-inflammatory and anti-proliferative
properties mediated in part by its ability to reduce gene expression of inflammatory
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mediators interleukin- 2 and interferon gamma [7]. The anti-inflammatory and anti-
proliferative properties of calcitriol may reduce cell turnover, thus potentially reducing
their telomere length attrition [7].
Limited population studies have assessed the association between circulating 25(OH)D
concentration [the most commonly used nutritional biomarker of vitamin D] and telomere
length [4,8–16]. A recent study [9] demonstrated that only at insufficient concentrations of
25(OH)D (50–75 nmol/L), telomerase activity is associated with survival times in CHD
patients (mean age 59.9 years-old). The findings by Richards et al. [10] and Liu et al. [11]
demonstrated a positive association between 25(OH)D concentration and leukocyte telom-
ere length (LTL) in women. On the other hand, a cross-sectional study of 2483 men aged
40–75 years did not observe a positive association between vitamin D biomarkers (25(OH)D
and 1,25(OH)2D) and LTL [12]. Liu et al. [13] also found no association between absolute
25(OH)D concentrations and long LTL, for the overall population or the subgroups in
the study (men, women, black and white separately) although maintaining a 25(OH)D
concentration ≥30 nmol/L was significantly associated with longer LTL in white partici-
pants only. Yet, Zhu et al. [14] showed an increase in telomerase activity in 19 overweight
African-American women after 16 weeks of vitamin D supplementation.
These conflicting results may be attributed to the differences between gender, race and
ages of study participants. For instance, the age range in one study was 48–93 years-old
(a mean age of 62.8 years-old) [13], whereas Richards et al. [10] studied younger women
aged 18–79 years-old (a mean age of 49.4 years-old). Besides, other studies failed to prove
the association between 25(OH)D and telomere length in younger participants (mean age
31–39 years-old [15] [16]). Generally, these studies included a wide age range of participants
with limited number of either very-old adults or participants younger than 70 years-old,
or participants of only one sex, which limited the generalizability of the findings for those
older than 80 years-old. Therefore, this study aimed to use the large dataset on both sexes
from the Newcastle 85+ Study to examine the association between 25(OH)D concentration
and telomere length in very-old adults (>85 years-old) [17] at baseline and after 18 and
36 months. We hypothesize that, by controlling related lifestyle factors, a concentration of
25(OH)D <25 nmol/L (used to define vitamin D deficiency) will be associated with shorter
telomere length in very-old adults.
2. Materials and Methods
2.1. Population Sample
The participants were taken from the Newcastle 85+ Study, which included both
community-dwelling and institutionalised older adults aged 85 years-old at recruitment
and living in Newcastle-upon-Tyne and North Tyneside. Commencing in 2006, the study
recruited a birth-cohort of more than 1000 adults aged 85 years from North-East England
to understand in great detail, the biological, clinical and social determinants of health as
the cohort ages. The study seeks to provide extensive data on the relevance of various
social, molecular and cellular indicators in contributing to health of very old people [18].
Health assessments, which comprised questionnaires, measurements, function tests and
a fasting blood sample as well as general practice (GP) medical records from which to
extract data on diagnosed diseases and prescribed medication, were available for the
851 participants. The current paper includes those Newcastle 85+ Study participants
(N = 775) whose data on health assessment, general practice records and 25(OH)D concen-
trations were available [18].
2.2. Ethical Approval
The study conformed with requirements set in the Declaration of Helsinki. The
Newcastle and North Tyneside Research Ethics Committee granted ethical approval,
and the participants provided signed informed consent (research project reference number:
06/Q0905/2).
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2.3. Circulating 25(OH)D Assay and Definition of Vitamin D Status
Following an overnight fast, 40mL of blood was drawn from the participants via the
antecubital vein between 7:00 am and 10:30 am. The majority of whole blood samples
(95%) were received at the laboratory for processing within 1 h of venepuncture. The
total 25(OH)D concentration in serum was estimated by the DiaSorin radio-immunoassay
(RIA) kit (DiaSorin Corporation, Stillwater, MN) as described previously [19]. Circulating
25(OH)D measurements were only available at baseline sampling [19].
United Kingdom Scientific Advisory Committee on Nutrition (SACN) cut-offs,
which are used for the dietary recommendations for the UK population, are used [20].
A circulating concentration of 25(OH)D < 25 nmol/L was used to indicate the risk of
vitamin D deficiency [20].
2.4. Telomere Length
Telomere length of peripheral blood mononuclear cell (PBMCs) was measured as an
abundance of telomeric template versus a single gene by quantitative real-time PCR. The
intra-assay coefficient of variation was 2.7% while the inter-assay coefficient of variation
was 5.1% [19]. Four internal control DNA samples were run within each plate to correct for
plate–to-plate variation. The measurements were performed in quadruplicate. All PCRs
were carried out on an Applied Biosystems 7900HT Fast Real Time PCR machine (Applied
Biosystems, Foster City, CA, USA) with a 384-well plate capacity [19].
Aviv et al. 2006 [21] proposes guidance for epidemiological research on the minimum
numbers of subjects required for a given age range to determine whether the extrapolated
telomere attrition rate of two groups are significantly different. For longitudinal studies
assessing telomere length in older adults (>60 years) over time, the sample size required
in each test group being compared for 80% power and p < 0.05 using a two sided t-test is
104 participants [21]. However, given the limited data on telomere attrition in those aged
85–88 years (the age range of the participants in this analysis), any power calculations for
very old populations are purely speculative.
2.5. HbA1c Measurement
The glycosylated haemoglobin % (HbA1c) was measured using a Tosoh Eurogenetics
automated HLC-723G7 HPLC analyser (Tosoh Bioscience, Tokyo, Japan) [19].
2.6. Other Health and Lifestyle Variables
2.6.1. Health and Morbidity
Information on health and morbidity was collected from GP medical records by
a trained nurse. Diseases were recorded via a predetermined list of key diseases. All
diagnoses of listed diseases were scored as present (score 1) or absent (score 0), together
with the date of first diagnosis. A simple disease count was used (maximum score 18) from
selected chronic diseases (See Supplementary Box S1). The participants were included only
if all of the variables were scored as present or absent [18].
2.6.2. Lifestyle
The multidimensional health questionnaire included gender (men or women) and
lifestyle factors (smoking, alcohol consumption and physical activity). Using data from
the Newcastle 85+ pilot study, a physical activity questionnaire (PAQ) was developed
and tested in this age range before being implemented. The participants were divided
into three groups: low (scores 0–1), moderate (scores 2–6), and high (scores 7–18) on the
PAQ. Physical activity levels are classified based on the frequency and intensity of physical
activity performed each week (supplementary data Box S1, available in Age and Ageing
online) [22]. For smoking, participants were categorized as non-smokers and occasional
and regular smoker. In regard to alcohol consumption, participants were categorized as
non-drinkers, moderate drinkers and heavy drinkers. Nutritional status was assessed by
Nutrients 2021, 13, 4341 5 of 16
calculating body mass index (kg/m2) (BMI) from recorded height and weight and included
in the models owing to its influence on telomere length [23].
Vitamin D supplement use was divided into two categories: no supplement users
and supplement users. Because the only information available on supplement use was
the brand and type, micronutrient-containing supplements were assumed to be taken
according to the manufacturer’s instructions. The use of vitamin D supplements (yes/no)
was collected via the interviewer-administered questionnaire, and prescriptions for vitamin
D medicine were retrieved from GP records [24].
2.7. Statistical Analysis
The normality of the distributions was assessed by reviewing the histograms and Q-Q
plots, and the Shapiro-Wilk test was applied. Normally-distributed, continuous variables
are presented as means and standard deviations (SD), while non-Gaussian distributed
variables are presented as medians and interquartile ranges (IQR). The categorical data
are presented as percentages (with the corresponding sample size). Mann-Whitney and
Kruskal-Wallis tests were used for ordered and non-normally distributed continuous
variables, and a χ2 test for categorical variables.
The concentration of 25(OH)D was not normally distributed (and could not be nor-
malized by transformation, as described previously [25]). In addition, telomere length
was not normally distributed (and could not be normalized by transformation either).
The 25(OH)D concentration was categorized by SACN cut-offs points for vitamin D [19]:
<25 nmol/L (as low). In order to have equal participants distributed between the groups,
we used 25–50 nmol/L (as moderate) (used as reference in the analysis) and >50 nmol/L
(as high). To examine the association between 25(OH)D and telomere length at baseline,
18 months and 36 months, linear regression was used. The linearity and homoscedasticity
assumptions were tested with residual normality versus predicted values plots. Important
confounders were selected based on their clinical and theoretical relevance to the telomere
length. These variables were then fitted, removed, and refitted until the best possible
but parsimonious model was achieved while checking for model fit statistics throughout.
Model 1 is an unadjusted model, Model 2 is adjusted for smoking and alcohol consumption,
Model 3 is further adjusted for BMI and physical activity, and Model 4 is further adjusted
for HbA1c. The models were stratified by sex.
All analyses were performed using IBM’s SPSS Statistics software, version 24 (IBM,
New York, NY, USA), and p < 0.05 was considered statistically significant.
3. Results
3.1. Participants’ Characteristics
By using the 3 cut-off of 25(OH)D concentration (low, moderate and high), there are
significant differences between men and women, BMI categories, PA level, vitamin D
containing medication and supplements usage, their general health rate, telomere length
and HbA1c measurement (Table 1). The majority of the participants were women, have
normal weight, moderately active, non-alcohol drinker, regular smokers and rate their
health as good.
3.2. Predictors of Telomere Length
No significant association was found between telomere length and the relative con-
founders from the literature, such as smoking, alcohol consumption, PA, BMI, vitamin D
containing medication usage, supplement, disease count and HbA1c% amongst all the
participants. The only significant association was between telomere length and sex
(95% CI = 0.000–0.001, p < 0.001). In addition, no significant association was found between
telomere length and the confounders when the participants were stratified by sex, except
for the BMI among the women (95% CI = 0.0034–0.044, p = 0.039).
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(n = 778) p
Women % (n) 64.4 (123) 53.8 (162) 65.7 (186) 60.8 (471) 0.007
BMI
0.015
Underweight % (n) 22.2 (39) 30.0 (86) 35.5 (91) 30.0 (216)
Normal weight % (n) 43.8 (77) 46.0 (132) 41.0 (105) 43.7 (314)
Overweight % (n) 19.9 (35) 14.6 (42) 17.2 (44) 16.8 (121)
Obese % (n) 14.2 (25) 14.2 (25) 6.3 (16) 9.5 (68)
PA
0.001
Low % (n) 28.6 (54) 15.4 (46) 24.8 (70) 22.1 (170)
Moderate % (n) 48.1 (91) 131 (44) 38.3 (108) 42.9 (330)
High % (n) 23.3 (44) 40.6 (121) 36.9 (104) 35.0 (269)
Alcohol drinkers
0.056
Never % (n) 42.9 (81) 40.1 (120) 40.7 (113) 41.0 (314)
Moderate % (n) 30.2 (57) 39.5 (118) 41.0 (114) 37.7 (289)
Heavy % (n) 11.6 (22) 10.7 (32) 9.4 (26) 10.4 (80)
Smoking
0.447
Never % (n) 36.6 (70) 33.3 (100) 36.2 (102) 35.2 (272)
Occasional % (n) 4.2 (8) 6.3 (19) 4.6 (13) 5.1 (40)
Regular % (n) 59.2 (113) 60.3 (181) 59.2 (167) 59.6 (461)
Vitamin D containing
medication % (n) 0.0 (1) 6 (17) 38 (108) 16.5 (126) <0.001
Supplement users % (n) 4.7 (9) 16.9 (51) 32.5 (92) 19.5 (152) <0.001
Self-rated health
0.006
Very good % (n) 37.7 (72) 40.5 (122) 41.7 (118) 40.3 (312)
Good % (n) 53.9 (103) 56.1 (169) 55.1 (156) 55.2 (428)
Poor % (n) 6.3 (12) 2.1 (6) 2.1 (6) 3.0 (23)
Disease count mean (SD) 4.9 (1.8) 4.7 (1.6) 4.8 (1.9) 4.8 (1.8) 0.675
Telomere length
sample % (n)
0.678At baseline 44.7 (190) 42.3 (291) 42.3 (271) 42.9 (752)
At 18 months 32.2 (137) 32.6 (224) 33.7 (216) 32.9 (577)
At 36 months 23.0 (98) 25.0 (172) 23.9 (153) 24.1 (423)
Telomere length (kb)
Median (IQR)
0.006At baseline 3827.1 (1641) 3721.0 (1094) 4009.5 (1021) 4034.6 (800.1)
At 18 months 3809.2 (236) 3811.8 (542) 3678.5 (487) 3785.2 (415.5)
At 36 months 2702.1 (1184) 2718.9 (1142) 2781.3 (842) 2832.7 (741.2)
HbA1c (%) mean (SD) 6.1 (1.1) 6.0 (0.7) 5.8 (0.6) 5.9 (0.7) 0.025
BMI: body mass index. HbA1c: glycated haemoglobin. Kb: kilo-base pair. p: p-value. Mann-Whitney U test for continuous non-normally
distributed variables or χ2 test for categorical variables. 25(OH)D: <25 nmol/L (low), 25–50 nmol/L (moderate), >50 nmol/L (high).
3.3. Circulating 25(OH)D Concentration and Telomere Length among the Very-Old Adults
at Baseline
A positive association was found between 25(OH)D and telomere length in very-old
adults (See Figure 2 for the distribution of 25(OH)D concentrations by telomere length
at baseline). Participants with 25(OH)D concentration >50 nmol/L had longer telom-
ere length compared to those with concentration <50 nmol/L in the unadjusted model
(95% CI = 17.8–109.9, B = 63.9 ± 23.4, p = 0.007), and even after adjusting for relevant
confounders, such as smoking, alcohol consumption, BMI, physical activity and HbA1C
(95% CI = 12.0–110.3, B = 61.29 ± 25.0, p = 0.015) (Table 2).
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Moderate (ref) (ref) (ref)
High 61.2 12.0, 110.3 0.015
CI: confidence interval. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and
>50 nmol/L (high). Ref: reference group. BMI: body mass index. HbA1c: glycated haemoglobin. Model 1 is the
unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and
physical activity. Model 4 is further adjusted for HbA1c%.
3.4. Circulating 25(OH)D Concentration and Telomere Length by Sex
Since sex was the only predictor of telomere length that was found for the current
participants, the participants were stratified using this factor. When the participants were
stratified by sex (Table 3), the very-old men with concentration between <25 nmol/L
were more likely to have shorter telomere length compared to those with concentration
25–50 nmol/L in the unadjusted model (95% CI = 1.9–473.4, B = 237.7 ± 119.7, p = 0.048)
and even after adjusting for relevant confounders (95% CI = 14.9–521.6, B = 268.3 ± 128.6,
p = 0.038).
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Table 3. Association between 25(OH)D cut-offs and telomere length by sex at baseline.
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High 65.1 −0.7, 131.1 0.053
CI: confidence interval. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and
>50 nmol/L (high). Ref: reference group. BMI: body mass index. HbA1c: glycated haemoglobin. Model 1 is the
unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and
physical activity. Model 4 is further adjusted for HbA1c%.
In contrast, the very-old women with 25(OH)D concentration >50 nmol/L were more
likely to have longer telomere length compared to those with concentration 25–50 nmol/L
in the unadjusted model (95% CI = 15.6–137.3, B = 76.4 ± 30.9, p = 0.014). This association
continued after further adjustments were made for smoking, alcohol consumption, BMI,
and physical activity (95% CI = 6.8–138.1, B = 72.4 ± 33.3, p = 0.030) but it disappeared
after adjusting for HbA1c (95% CI = −0.7–131.1, B = 65.1 ± 33.5, p = 0.053).
3.5. Circulating 25(OH)D Concentration and Telomere Length among the Very-Old Adults at
18 Months
A negative significant association was found between 25(OH)D concentration and
telomere length at 18 months (See Figure 3 for the distribution of 25(OH)D concentra-
tions by telomere length at 18 months). Very-old participants with 25(OH)D concen-
tration >50 nmol/L were more likely to have shorter telomere length compared to those
with concentration 25–50 nmol/L in the unadjusted model (95% CI = −55.9–−5.8,
B = −30.9 ± 12.7, p = 0.016), and after adjusting for relevant confounders, such as smoking,
alcohol consumption, BMI, physical activity and HbA1C HbA1C (95% CI = −59.9–−7.5,
B = −33.7 ± 13.3, p = 0.012) (Table 4).
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3.6. Circulating 25(OH)D Concentration and Telomere Length by Sex at 18 Months
When the participants were stratified by sex (Table 5), a negative association was
found between 25(OH)D and Telomere Length in the very-old m n. Very-old men with
c ncentra ion >50 nmol/L were more likely to ave shorter te omere length compared to
those with concentrati n <50 nmol/L in the unadjusted model (95% CI = −107.3–−25.5,
B = −66.2 ± 20.8, p = 0.002) and even after adjusting for relevant confounders
(95% CI = −107.0–−23.3, B = −65.2 ± 21.2, p = 0.002).
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4. Discussion
4.1. Main Findings
To our knowledge, this is the first study which has examined the prospective associa-
tion between circulating 25(OH)D concentration and telomere length in very-old adults
(≥85 years). Our results show that in fully adjusted models, whilst there was a signifi-
cant positive association between 25(OH)D (>50 nmol/L) and telomere length at baseline,
the direction of association was reversed after 18 months and absent at 36 months. How-
ever, it should be noted that the strength of the positive and negative associations between
25(OH)D concentration and telomere length at baseline and 18, respectively were weak
[adjusted R square 0.004 at baseline and 0.020 at 18 months].
4.2. Evidence from Other Studies
Telomeres, the specific DNA protein structures, are found at both ends of each chromo-
some. Their function is to protect the genome from nucleolytic degradation, unnecessary
recombination, repair, and interchromosomal fusion [1]. Each DNA replication causes
telomere shortening, and when the telomere length reaches a critical limit, the cell under-
goes senescence and/or apoptosis [2]. The rate attrition differs between individuals and
tissues, and is influenced by multiple factors. Inflammation and oxidative stress are the
key determinants of telomere length, and even though some of the factors that heighten
oxidative stress and inflammation are genetic, others are environmental in nature, such as
smoking, alcohol consumption, obesity and a sedentary lifestyle. Moreover, several dietary
factors, such as high energy consumption and the intake of high sugar foods, are also highly
associated with inflammation [4,26]. While these lifestyle habits may be difficult to change,
vitamin D concentration was easily modifiable through nutritional supplementation or
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sunlight exposure. Taking all of this into account, we sought to explore and study the
association between 25(OH)D concentration and telomere length.
Our findings were in agreement with previous findings from two large studies on
women by Richards et al. [10] and Liu et al. [11] ] (n = 2160 and n = 4604 participants,
respectively). Both studies found that a higher 25(OH)D concentration was associated with
longer LTL [10,11]. Also, a recent study by Zarei et al. [8] found an interaction between
vitamin D and telomerase with regards to their relationship with the survival among
404 CVD patients. On the other hand, the findings from a large community-dwelling study
conducted by Liu and colleagues [13], failed to find any association between continuous
25(OH)D concentrations and longer LTL not only for their entire population (n = 1154) but
also in the white (n = 503), black (n = 651), female (711), male (447) or race–sex subgroups.
However, they found that concentrations of vitamin D ≥30 nmol/L were significantly
associated with longer LTL in whites only [13].
In a prospective study of 59 African-American systemic lupus erythematosus patients
and their counterpart control subjects shorter telomeres were seen among all subjects with
a 25(OH)D concentration <50 nmol/L [16]. Interestingly, the patients who remained vita-
min D deficient after three months of follow up (n = 29), tended to have shorter telomeres
than those patients whose 25-hydroxyvitamin D levels were replete [16], suggestive of
a protective role of 25(OH)D in maintaining telomere length. Moreover, a large community-
dwelling study conducted by Mazidi and colleagues [7], examined the association between
25(OH)D concentration and telomere length across a broad age range (age: 18–80 years
old). The participants were free of any history of diabetes, coronary heart disease, angina,
myocardial infarction, stroke or congestive heart failure, in both men (n = 2319) and women
(n = 2668) [7]. A positive association was demonstrated between 25(OH)D concentration
and telomere length in the limited-adjusted models. Both studies highlighted the possible
role of 25(OH)D concentration in the maintenance of telomere length [7,16].
Our study also demonstrated an association between 25(OH)D and telomere length
in men, which is inconsistent with a cross-sectional study in white men (n = 2483),
which failed to observe an association between any of the vitamin D biomarkers (25(OH)D
and 1,25(OH)D) and LTL [12]. However, the participants in the study by Julin et al. [12]
were younger than our participants (the mean age was 64.1 years old). Furthermore, they
defined 25(OH)D concentration by four quartiles with higher cut-offs (<50 nmol/L was the
lowest quartile) while the current study showed that a 25(OH)D concentration >50 nmol/L,
was positively associated with telomere length at baseline.
Regarding the contribution of sex to the association between 25(OH)D concentration
and telomere length, several biologically plausible explanations for a difference between
men and women have been suggested, such as men, in general, having shorter telomeres
than women [27]. In addition, estrogen can stimulate the production of telomerase and
is a potent antioxidant and regulator of antioxidant genes [28]. Therefore, it should be
noted that the differences in sex could contribute toward the association between vitamin
D status and telomere length.
Regarding the negative association between 25(OH)D concentration and telomere
length at 18 months, the plausible explanations could be that 25(OH)D concentration was
only measured at baseline and not at follow up phases. Another explanation could be
that concentration >50 nmol/L might not have protective effect on telomere length at
very-old age. However, it should be considered that the model is not explaining much of
the variation (Adj R2 considered very low). Besides, the 95% CIs were wide even when
the relationship was positively significant at baseline indicates a less precise estimate
of the relationship. That said, we could not ascertain the protective association of high
concentration of 25(OH)D on telomere length in very-old adults in the current population.
There are several potential mechanisms that may explain the association between
telomere length and 25(OH)D concentration. Generally, an activated form of vitamin D
has autocrine and paracrine roles, including reducing telomere shortening through both
anti-inflammatory and antiproliferative mechanisms. First, the active form of vitamin D
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decreases the mediators of systemic inflammation, such as interleukin-2 and tumor necro-
sis factor [9]. Furthermore, vitamin D receptor is expressed in the T and B lymphocytes,
natural killer cells, and monocytes, which promote the down-regulation of cytokines and
other proinflammatory factors. Thus, it follows that vitamin D would attenuate the rate
of telomere length attrition [7,29]. In addition, the retinoid x receptor (which is found
widely distributed in cells and tissues and acts as the major contributor to vitamin D
dependent transcription) may attenuate the relationship between vitamin D and telomere
length has other roles in the cell that are independent of the vitamin D pathway. Therefore,
the association between one common variant and a long telomere length does not necessar-
ily imply a link between 25(OH)D and telomere length [12].
4.3. Strengths and Limitations
The study has several strengths, including its unique design, as well as the fact that the
analysis is concentrated on a broadly representative age category of 85 years old; and that
the statistical assumptions were met. Another key strength is that the study was adjusted for
major potential confounders associated with telomere length (e.g., BMI, physical activity,
smoking). It should also be noted however, that the findings reported here should be
interpreted with caution due to the following limitations: firstly, its epidemiological design
restricts any inference about causal relationships. Secondly, we did not include wider
dietary factors as covariates in our models as we had no a priori knowledge from our
dataset that these factors could associate with telomere length. As a result, unmeasured or
uncontrolled factors may confound the findings, raising the risk of Type I error. Adding
more confounders to the fully adjusted model, on the other hand, may have resulted in
non-significant (bias) results and decreased power to detect significant relationships. Third,
despite having longitudinal telomere length data spanning 36 months, serum 25(OH)D
data was only collected at baseline.
5. Conclusions
Among the very-old in the Newcastle 85+ cohort study, 25(OH)D concentration was
positively associated with telomere length at baseline. However, given the wide 95% CI
and the conflicting directions of the associations at 18 months inclined to say that high
concentration of 25(OH)D (>50 nmol/L) did not show protective effect on telomere length
in very-old adults. In conclusion, high 25(OH)D concentration is positively associated with
telomere length but does not have protective effect over time.
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